[1] 万古霉素临床应用剂量专家组.万古霉素临床应用剂量中国专家共识[J].中华传染病杂志,2012,30(11):641-646.
[2] Liu C,Bayer A,Cosgrove S E,et al.Clinical practice guidelines by the infectious diseases society of America for the treatment of Methicillin-Resistant Staphylococcus aureus infections in adults and children:executive summary[J].Clin Infect Dis,2011,52(3):285-292.
[3] 耐甲氧西林金黄色葡萄球菌感染防治专家委员会.耐甲氧西林金黄色葡萄球菌感染防治专家共识[J].中华实验和临床感染病杂志(电子版),2010,4(2):215-223.
[4] 陈春辉,李光辉.美国感染病学会治疗成人及儿童甲氧西林耐药金黄色葡萄球菌感染临床实践指南[J].中国感染与化疗杂志,2011,11(6):428-435.
[5] Rybak M, Lomaestro B, Rotschafer JC, et al.Therapeutic monitoring of vancomycin in adult patients:a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists[J]. Am J Health Syst Pharm,2008,66(1):82-98.
[6] van Hal SJ, Paterson DL, Lodise TP. Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain troughs between 15 and 20 milligrams per liter[J]. Antimicrob Agents Chemother, 2013,57(2):734-744.
[7] 黄榜江,肖政,汪成琼,等.我国慢性阻塞性肺病院内真菌感染特征及高危药物因素的Meta分析[J].实用医学杂志,2015,31(1):110-115.
[8] Higgins Jpt GS. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0[J]. Cochrane Database of Systematic Reviews,2011,2011(2):S38.
[9] 吴泰相,商洪才,卞兆祥.随机对照实况试验的概念,设计和实施[J].中国循证医学杂志,2009,9(12):1277-1280.
[10] 陈耀龙,李晓,梅又文,等.循证医学术语介绍V[J].中国循证医学杂志,2009,9(7):734-739.
[11] Wysocki M, Thomas F, Wolff MA, et al. Comparison of continuous with discontinuous intravenous infusion of vancomycin in severe MRSA infections[J]. J Antimicrob Chemother, 1995,35(2):352-354.
[12] Wysocki M, Delatour F, Faurisson F, et al. Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections:prospective multicenter randomized study[J]. Antimicrob Agents Chemother, 2001,45(9):2460-2467.
[13] Vuagnat A, Stern R, Lotthe A, et al. High dose vancomycin for osteomyelitis:continuous vs. intermittent infusion[J]. J Clin Pharm Ther,2004,29(4):351-357.
[14] Hutschala D, Kinstner C, Skhirdladze K, et al. Influence of vancomycin on renal function in critically ill patients after cardiac surgery:continuous versus intermittent infusion[J]. Anesthesiology,2009,111(2):356-365.
[15] Ingram PR, Lye DC, Fisher DA, et al. Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapy[J]. Int J Antimicrob Agents, 2009,34(6):570-574.
[16] Schmelzer TM, Christmas AB, Norton HJ, et al. Vancomycin intermittent dosing versus continuous infusion for treatment of ventilator-associated pneumonia in trauma patients[J]. Am Surg, 2013,79(11):1185-1190.
[17] Hanrahan TP, Harlow G, Hutchinson J, et al. vancomycin-associated nephrotoxicity in the critically ill:a retrospective multivariate regression analysis[J]. Crit Care Med, 2014,42(12):2527-2536.
[18] Di Filippo A,De Gaudio AR,Novelli A,et al.Continuous infusion of vancomycin in methicillin-resistant staphylococcus infection[J].Chemotherapy,1998,44(1):63-68.
[19] Akers KS,Cota JM,Chung KK,et al.Serum vancomycin levels resulting from continuous or intermittent infusion in critically ill burn patients with or without continuous renal replacement therapy[J].J Burn Care Res,2012,33(6):e254-e262.
[20] Saugel B,Nowack MC, Hapfelmeier A,et al.Continuous intravenous administration of vancomycin in medical intensive care unit patients[J].J Crit Care,2013,28(1):9-13.
[21] 薛敬一,徐晓涵,陈恳,等.万古霉素持续输注与间断输注的系统评价与Meta分析[J].中国临床药理学杂志,2015,31(13):1348-1352.